- Home
- AIR vs DNLI Comparison
AIR vs DNLI Comparison
Compare AIR & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIR
- DNLI
- Stock Information
- Founded
- AIR 1951
- DNLI 2013
- Country
- AIR United States
- DNLI United States
- Employees
- AIR N/A
- DNLI N/A
- Industry
- AIR Aerospace
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AIR Industrials
- DNLI Health Care
- Exchange
- AIR Nasdaq
- DNLI Nasdaq
- Market Cap
- AIR 2.2B
- DNLI 1.9B
- IPO Year
- AIR 1988
- DNLI 2017
- Fundamental
- Price
- AIR $61.39
- DNLI $13.24
- Analyst Decision
- AIR Strong Buy
- DNLI Strong Buy
- Analyst Count
- AIR 6
- DNLI 15
- Target Price
- AIR $80.67
- DNLI $33.85
- AVG Volume (30 Days)
- AIR 204.1K
- DNLI 1.3M
- Earning Date
- AIR 07-17-2025
- DNLI 05-06-2025
- Dividend Yield
- AIR N/A
- DNLI N/A
- EPS Growth
- AIR N/A
- DNLI N/A
- EPS
- AIR N/A
- DNLI N/A
- Revenue
- AIR $2,682,500,000.00
- DNLI N/A
- Revenue This Year
- AIR $18.46
- DNLI N/A
- Revenue Next Year
- AIR $5.10
- DNLI $256.73
- P/E Ratio
- AIR N/A
- DNLI N/A
- Revenue Growth
- AIR 21.07
- DNLI N/A
- 52 Week Low
- AIR $46.51
- DNLI $10.57
- 52 Week High
- AIR $76.34
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- AIR 56.95
- DNLI 41.80
- Support Level
- AIR $58.83
- DNLI $12.86
- Resistance Level
- AIR $63.20
- DNLI $13.77
- Average True Range (ATR)
- AIR 1.42
- DNLI 0.75
- MACD
- AIR 0.04
- DNLI -0.11
- Stochastic Oscillator
- AIR 58.67
- DNLI 14.07
About AIR AAR Corp.
AAR Corp is engaged in providing products and services to aviation, government, and defense market. It operates in three segments namely Parts Supply, Repair & Engineering, and Integrated Solutions. The parts supply segment majorly consists of sales and leasing of USM and aftermarket distribution of new, OEM-supplied replacement parts. Repair & Engineering segment provides airframe maintenance, component repair, and landing gear overhaul services. Integrated Solutions segment majorly consists of its fleet management and operations of customer-owned aircraft, customized performance-based supply chain logistics programs in support of the U.S. Department of Defense and foreign governments, flight hour component inventory and repair programs for commercial airlines.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.